Actinium Pharmaceuticals Obtains $3,310,860 New Financing Round

  • Feed Type
  • Date
    1/22/2014
  • Company Name
    Actinium Pharmaceuticals
  • Mailing Address
    501 Fifth Avenue 4th Floor New York, NY 10017
  • Company Description
    Actinium Pharmaceuticals, Inc. (API) is a privately held biopharmaceutical company specialized in the development of cancer drugs.
  • Website
    http://www.actiniumpharmaceuticals.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $3,310,860
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy